Recent research has demonstrated the potential of nanozymes, or nanoscale enzymes, to act as a tumor-specific drug delivery system. Nanozymes have been found to be highly effective in delivering drugs directly to the tumor cells, while minimizing the impact on healthy tissue. This breakthrough could revolutionize the way cancer is treated, providing a safer, more efficient approach to drug delivery. Additionally, the nanoscale size of nanozymes make them ideal for penetrating the tumor-associated stroma, or extracellular matrix. This allows for the drug to be more uniformly distributed within the tumor, leading to improved therapeutic efficacy.

Read Full Article Here

source: Phys.org